Oncology Precision Medicine Market Size is projected to reach USD 124.84 billion by 2030, growing at a CAGR of 10.85%: Straits Research
July 28, 2022 15:00 ET
|
Straits Research
New York, United States, July 28, 2022 (GLOBE NEWSWIRE) -- The term "Oncology precision medicine" refers to a medical approach that aims to jointly combine the results and efforts of research and...
Insilico Medicine Appoints Sujata Rao, M.D., as Senior Vice President to Oversee Clinical Development
July 19, 2022 10:00 ET
|
InSilico Medicine
New York, July 19, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI) driven drug discovery company, has appointed Dr. Sujata Rao as Senior Vice...
Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for Ebola
July 07, 2022 16:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md. and MIAMI, July 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement with Ridgeback Biotherapeutics (“Ridgeback...
Coya Therapeutics Announces Peer-Reviewed Publication of its First-in-Class Regulatory T Cell-derived Exosomes and their Therapeutic Potential in Neurodegeneration and Inflammation Related Diseases
June 23, 2022 09:27 ET
|
Coya Therapeutics, Inc.
Regulatory T Cell (Treg)-derived exosome data have been published in the peer-reviewed journal Frontiers of Immunology Characterization of Treg-derived exosomes show Treg cells-conserved functional...
Coya Therapeutics Secures Option Agreement for Exclusive Worldwide Rights to Exosome Engineering Technology from Carnegie Mellon University
June 15, 2022 09:27 ET
|
Coya Therapeutics, Inc.
Proprietary technology generates Exosome Polymer Hybrids (EPHs) which allow for efficient and versatile method of customizing cargoes of Treg-derived exosomes using oligonucleotide tethers ...
7 Hills Pharma Expands Pioneering Patent Portfolio With New Claims Covering Innovative Combination Therapies
June 09, 2022 19:53 ET
|
7 Hills Pharma
HOUSTON, June 09, 2022 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC (“7 Hills” or “7HP”) has secured newly issued US patent claims that significantly expand the extent of the company’s intellectual...
Coya Therapeutics Secures $10 Million Financing to Advance Clinical and Pre-Clinical Pipeline of Regulatory T Cell Therapeutics
June 07, 2022 10:02 ET
|
Coya Therapeutics, Inc.
Coya Therapeutics’ clinical and biomarker data continue to demonstrate regulatory T cells (Tregs) ability to meaningfully dampen both systemic and neuroinflammation, thereby restoring the immune...
Compass Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference
May 31, 2022 08:00 ET
|
Compass Therapeutics
BOSTON, May 31, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...
Compass Therapeutics to Host Conference Call Highlighting Clinical Data from CTX-009
May 03, 2022 16:01 ET
|
Compass Therapeutics
Call scheduled for Wednesday, May 4, 2022 at 8:00 a.m. ET Key Opinion Leader to Participate BOSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage...
North America Precision Medicine Market size to surpass $50bn by 2027, says Graphical Research
May 02, 2022 07:07 ET
|
Graphical Research
Pune, India, May 02, 2022 (GLOBE NEWSWIRE) -- As per a recent industry report put forward by Graphical Research, the North America precision medicine market is forecast to register its name in the...